Skip to main content
Uncategorized

The Bosch i Gimpera Foundation participates in a cell therapy program to drive translational research

By 19 de August de 2010November 18th, 2020No Comments
< Back to news
 19.08.2010

The Bosch i Gimpera Foundation participates in a cell therapy program to drive translational research

The Universitat de Barcelona (UB), the Hospital Clínic, the Institut d'Investigacions Biomèdiques August Pi i Sunyer (IDIBAPS) and the Institut d'Investigació Biomèdica de Bellvitge (IDIBELL) announced that they will work together on a Cell Therapy Program (TCUB) to drive translational research in this field of science. The new Program, which receives support from the Government of Catalonia –with 200,000 euros in investment over the next two years–, will coordinate 24 top-notch research groups. For now, 19 of these groups focus on clinical research (18 from IDIBAPS and one from IDIBELL) and the other five will contribute basic laboratory knowledge and belong to the UB Faculty of Medicine.

The focus of this research is varied, including neurology and the musculoskeletal system, diabetes and metabolism, hemato-oncology, pulmonology, ophthalmology, immunology and infectious diseases, the digestive system, and transplants. In addition to sharing knowledge and developing new protocols to differentiate and grow stem cells, the Program also expects to organize seminars and work meetings, hire technical support staff and fund intramural projects.

Each team has their own resources, which they have obtained through competitive calls for proposals. In total, there are 74 active cell therapy projects, with a total budget of 3.5 million euros. 17 of these projects are international, 53 national and four from private foundations.

More information